Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
-
* Corresponding author: Javier Benítez jbenitez@cnio.es
1 Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Center (CNIO), Madrid, E-28029, Spain
2 Breast and Gynecological Group, Molecular Pathology Program, Spanish National Cancer Research Center (CNIO), Madrid, E-28029, Spain
3 The Institute of Cancer SOLCA, Cuenca, Ecuador
4 Department of Medicine, Medical Genetics, Abramson Cancer Center, University of Pennsylvania (UPENN), Philadelphia, PA-19104, USA
5 Center for Biomedical Research on Rare Diseases (CIBERER), Calle de Alvaro de Bazan, 10 Bajo, 46010 Valencia, Spain
6 Current address: The Breakthrough Breast Cancer Research Center, The Institute of Cancer Research (ICR), SW3 6JB, UK
Breast Cancer Research 2009, 11:R86 doi:10.1186/bcr2456
Published: 8 December 2009Additional files
Additional file 1:
Word document containing a table showing genes, primers and Universal Probe Library from Roche© used for qRT-PCR analyses in the present study.
Format: DOC Size: 71KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Word file containing a table listing the antibodies used in the present immunohistochemical analysis and thresholds established to consider a tumor as positive.
Format: DOC Size: 60KB Download file
This file can be viewed with: Microsoft Word Viewer
